| 000 | 01234 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250514040310.0 | ||
| 264 | 0 | _c20021108 | |
| 008 | 200211s 0 0 eng d | ||
| 022 | _a0302-2838 | ||
| 024 | 7 |
_a10.1016/s0302-2838(02)00238-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBenaim, E A | |
| 245 | 0 | 0 |
_aGleason score predicts androgen independent progression after androgen deprivation therapy. _h[electronic resource] |
| 260 |
_bEuropean urology _cJul 2002 |
||
| 300 |
_a12-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAndrogen Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aPace, C M | |
| 700 | 1 | _aRoehrborn, C G | |
| 773 | 0 |
_tEuropean urology _gvol. 42 _gno. 1 _gp. 12-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0302-2838(02)00238-5 _zAvailable from publisher's website |
| 999 |
_c12012646 _d12012646 |
||